HOUSE OF REPRESENTATIVES
THE THIRTIETH LEGISLATURE
REGULAR SESSION OF 2019
|
Rep. John M. Mizuno, Chair |
|
Rep. Bertrand Kobayashi, Vice Chair |
|
Rep. Della Au Belatti |
Rep. Calvin K.Y. Say |
|
Rep. Nadine K. Nakamura |
Rep. James Kunane Tokioka |
|
Rep. Joy A. San Buenaventura |
Rep. Gene Ward |
NOTICE OF HEARING
|
DATE: |
Tuesday, March 12, 2019 |
|
TIME: |
9:00am |
|
PLACE: |
Conference Room 329 State Capitol 415 South Beretania Street |
A G E N D A
|
RELATING TO INSURANCE. Clarifies that the existing health insurance mandate for coverage of low-dose mammography includes coverage for advancing methodologies of digital mammography and breast tomosynthesis. Sunsets June 30, 2024. Effective July 1, 2050. (SD1)
|
HLT, CPC, FIN |
|
|
RELATING TO PALLIATIVE CARE. Establishes the culturally competent palliative care pilot program within the Department of Health to promote palliative care, gather health care utilization data, and conduct bidding for at least two pilot programs for home or community based palliative care, one of which must be located in a county with less than two hundred thousand residents. Requires reports to the legislature. Establishes an advisory group to oversee implementation of the pilot program. Appropriates funds. Effective 7/1/2050. (SD1)
|
HLT, CPC, FIN |
|
|
RELATING TO TAXATION. Establishes a non-refundable tax credit for the purchase of a personal emergency response system, under certain conditions. Applies to taxable years beginning after 12/31/2019. Effective 7/1/2050. (SD2)
|
HLT, CPC, FIN |
|
|
RELATING TO THE BOARD OF PHARMACY. Allows the board of pharmacy to approve pilot and demonstration projects for innovative applications in the practice of pharmacy under certain circumstances. (SD1)
|
HLT, CPC, FIN |
|
|
RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM. Specifies that a health care provider shall not be required to consult the electronic prescription accountability system for patients when the prescription will be directly administered under the supervision of a health care provider, provided that the system is consulted when the patients are initially admitted at a hospital; for patients in post-operative care with a prescription limited to a three-day supply; or for patients with a terminal disease receiving hospice or other palliative care. Clarifies that an informed consent agreement is not necessary for patients whose prescription will be directly administered under the supervision of a health care provider. (SD1)
|
HLT, JUD/CPC, FIN |
|
|
RELATING TO PRESCRIPTIVE AUTHORITY FOR CERTAIN CLINICAL PSYCHOLOGISTS. Authorizes and establishes procedures and criteria for prescriptive authority for clinical psychologists who meet specific education, training, and registration requirements. Requires the Board of Psychology to accept applications for prescriptive authority privilege beginning 7/1/2022. Requires the Board of Psychology to report to the Legislature prior to the Regular Session of 2021. Sunsets on 8/31/2025. Effective 7/1/2050. (SD2)
|
HLT, CPC, JUD, FIN |
|
|
RELATING TO PRESCRIPTIONS. Clarifies that existing law intended to curb over-access to and abuse of opioids, including the time frame for filling prescriptions, supply limitations, and requirements to check the state electronic prescription accountability system and execute an informed consent process, do not apply to qualifying patients who are prescribed or issued prescriptions pursuant to the State's Our Care, Our Choice act. (SD2)
|
HLT, JUD, FIN |
|
|
RELATING TO ADOLESCENT MENTAL HEALTH SERVICES. Prohibits health plans and providers from disclosing to a policyholder or other covered person any payment or billing information for a minor's mental health services if the minor received the services without the consent or participation of the minor's parent or legal guardian. Specifies that licensed mental health professionals providing mental health treatment to a minor have a standard of care duty to ask the minor if the minor wants the provision of mental health care services to be kept confidential from the minor's parent or guardian and explain to the minor the meaning of confidential mental health care services. Clarifies that a minor is not responsible for out-of-pocket payments, regardless of parent or guardian participation in treatment or services received. Specifies that the minor's parent or legal guardian is not responsible for out-of-pocket payments for minor-initiated mental health treatment or counseling services, except in certain circumstances. (SD1)
|
HLT, CPC, FIN |
|
|
RELATING TO HEALTH. Proposed HD1: Beginning 1/1/2020, requires the State's medicaid managed care and fee-for-service programs to provide coverage for home and community-based services for individuals diagnosed as having autism or fetal alcohol spectrum disorder. Requires the Department of Human Services to seek a section 1115 waiver to amend the state Medicaid plan to include this coverage. Establishes a task force in the Department of Health's Behavioral Health Services Administration to study access and service gap issues in providing essential services to the State's intellectually and developmentally disabled individuals. Effective7/1/2050. Beginning 1/1/2020, requires the State's medicaid managed care and fee-for-service programs to provide coverage for home and community-based services for individuals diagnosed as having autism or fetal alcohol spectrum disorder. Requires the Department of Human Services to seek a section 1115 waiver to amend the state Medicaid plan to include this coverage. Establishes a task force in the Department of Health's Behavioral Health Services Administration to study access and service gap issues in providing essential services to the State's intellectually and developmentally disabled individuals. Effective7/1/2050.
Copies of the proposed HD1 are available in room 402 and on the Legislature's Web site: http://www.capitol.hawaii.gov.
|
HLT, CPC, FIN |
|
|
RELATING TO HOME CARE AGENCIES. Makes permanent the licensure requirements for home care agencies licensed by the department of health. (SD1)
|
HLT, CPC, JUD |
|
|
RELATING TO MENTAL HEALTH. Facilitates the treatment of individuals with mental health issues. Provides that any interested party may file a petition for a mental health order for involuntary hospitalization or assisted community treatment alleging that another person has a mental illness and qualifies for assistance. Requires the court to assess whether a person meets the criteria for assisted community treatment before discharging a person who has been involuntarily hospitalized. Authorizes the court to order a person to obtain assisted community treatment as an alternative to involuntary hospitalization. Clarifies the criteria for assisted community treatment. Effective 3/15/2050. (SD2)
|
HLT, JUD, FIN |
|
|
RELATING TO HEALTH CARE PROFESSIONALS. Clarifies the list of acceptable institutions or organizations that can approve the continuing education courses needed by naturopathic physicians for license renewal. (SD1)
|
HLT, IAC, CPC |
|
|
RELATING TO CLINICAL VICTIM SUPPORT SERVICES. Clarifies that clinical victim support services for victims of sexual violence and abuse are a mental health outpatient services benefit required to be covered under health insurance policies offered by health insurers, mutual benefit societies, fraternal benefit societies, and health maintenance organizations. Effective 7/1/2050. (SD1)
|
HLT, CPC, FIN |
|
|
RELATING TO PHARMACY BENEFIT MANAGERS. Prohibits pharmacy benefit managers from engaging in self-serving business practices. Replaces registration requirement with license requirement for pharmacy benefit managers. Increases pharmacy benefit manager reporting requirements to the insurance commissioner. Increases application and renewal fees and penalties for failure to renew a license. Effective 7/1/2050. (SD2)
|
HLT, CPC/JUD, FIN |
|
|
RELATING TO PHARMACY BENEFIT MANAGERS. Establishes requirements for pharmacy benefit managers and maximum allowable cost, including the ability of pharmacies to receive comprehensive maximum allowable cost lists and bring complaints within the purview of the department of commerce and consumer affairs, rather than the department of health. Requires pharmacy benefit managers to disclose where an equivalent drug can be obtained at or below the maximum allowable cost when a maximum allowable cost is upheld on appeal and allow contracting pharmacies to reverse and rebill claims if the pharmacy benefit manager establishes a maximum allowable cost that is denied on appeal and pay the difference to the contracting pharmacies. Clarifies the available penalties for violations of maximum allowable cost requirements. Effective 7/1/2050. (SD1)
|
HLT, CPC/JUD, FIN |
|
|
RELATING TO ELECTRONIC SMOKING PRODUCTS. Establishes the offense of unlawful shipment of e-liquid products. Includes e-liquid and electronic smoking devices containing e-liquid within the definition of "tobacco products", as used in the cigarette tax and tobacco tax law. Increases the license fee for persons engaged as a wholesaler or dealer of cigarettes and tobacco products. Increases the retail tobacco permit fee for retailers engaged in the retail sale of cigarettes and tobacco products. Allocates a portion of funds collected from excise taxes on tobacco products to health education and prevention programs about the risks and dangers of the use of electronic smoking devices for youth. Repeals certain provisions of the Hawaii Revised Statutes relating to electronic smoking devices. Effective 3/15/2030. (SD2)
|
HLT, JUD, FIN |
|
|
RELATING TO FLAVORED TOBACCO PRODUCTS. Bans the sale of flavored tobacco products. Effective 1/1/2020. (SD2)
|
HLT, JUD, FIN |
|
|
|
|
|
|
RELATING TO HEALTH CARE. Requires health insurers, mutual benefit societies, and health maintenance organizations to provide coverage for a comprehensive category of reproductive health services, drugs, devices, products, and procedures. Prohibits discrimination in the provision of reproductive health care services. Effective 3/15/2094. (SD2)
|
HLT, CPC, FIN |
|
|
|
|
|
DECISION MAKING TO FOLLOW
Persons wishing to offer comments should submit testimony at least 24 hours prior to the hearing. Testimony should indicate:
· Testifier's name with position/title and organization;
· The Committee(s) to which the comments are directed;
· The date and time of the hearing; and
· Measure number.
While every effort will be made to incorporate all testimony received, materials received on the day of the hearing or improperly identified or directed, may be distributed to the Committee after the hearing.
Submit testimony in ONE of the following ways:
PAPER: 10 copies (including an original) to Room 403 in the State Capitol;
FAX: For testimony less than 5 pages in length, transmit to 808-586-6311 (Oahu) or 1-800-535-3859 (for Neighbor Islander without a computer to submit testimony through e-mail or the Web); or
WEB: For testimony less than 20MB in size, transmit from http://www.capitol.hawaii.gov/submittestimony.aspx.
Testimony submitted will be placed on the legislative website. This public posting of testimony on the website should be considered when including personal information in your testimony.
If you require special assistance or auxiliary aids and/or services to participate in the House public hearing process (i.e., sign or foreign language interpreter or wheelchair accessibility), please contact the Committee Clerk at 586-6050 or email your request for an interpreter to [email protected] at least 24 hours prior to the hearing for arrangements. Prompt requests submitted help to ensure the availability of qualified individuals and appropriate accommodations.
|
|
|
________________________________________ Rep. John M. Mizuno Chair |
|
|
|
|